Wycliffe Omwancha, Chahinaz kouba, Satish Yelamanchili, Steven H. Neau (2011)Colon-specific drug delivery using ethylcellulose and chitosan in the coat ofcompression-coated tablets. Drug Development and Industrial Pharmacy, 37(8),945-953.
Wong D, Larrabee S, Clifford K, Tremblay J, Friend DR. (1997) USP DissolutionApparatus III (reciprocating cylinder) for screening of guar-based colonic deliveryformulations. Journal of Controlled Release, 47(2), 173?179.
Willoughby, C.P., Aronson, J.K., Agback, H., Bodin, N.O., Truelove, S.C. (1982)Distribution and metabolism in healthy volunteers of disodium azodisalicylate apotential therapeutic agent for ulcerative colitis. Gut 23, 1081?1087.
Watanabe, S., Kawai, H., Katsuma, M., Fukui, M. (2001) Drug coated with anorganic acid-soluble polymer material and a saccharide, which rapidly generates anorganic acid by the action enterobacteria. U.S. Patent 6506407B2.
Watanabe S, Kawai H, Katsuma M, Fukui M. (1998) Colon specific drug releasesystem. U.S. Patent 6368629.
Wakerly, Z., Fell, J.T., Attwood, D., Parkins, D. (1996) Pectin / ethylcellulose filmcoating formulations for colonic drug delivery. Pharmaceutical Research, 13, 1210?1212.
Wakerly, Z., Fell, J., Attwood, D., Parkins, D. (1997) Studies on amidated pectins aspotential carriers in colonic drug delivery. Journal of Pharmaceutics &Pharmacology, 49, 622?625.
Vishal K. Gupta, Thomas E. Beckert, James C. Price (2000) A novel pH- and timebasedmulti-unit potential colonic drug delivery system. I. Development.International Journal of Pharmaceutics, 213, 83?91.
Vilivalam,V.D., Illum, L., Iqbal, K. (2000) Starch capsules: an alternative system fororal drug delivery. Pharmaceutical Science & Technology Today, 3, 64?69.
Vervoort, L., Kinget, R. (1996) In vitro degradation by colonic bacteria of inulin HPincorporated in eudragit films. International Journal of Pharmaceutics, 129, 185?190.
Vandelli MA, Leo E, Forni F, Bernabei MT. (1996) In vitro evaluation of a potentialcolonic delivery system that releases drug after a controllable lag-time. EuropeanJournal of Pharmaceutics and Biopharmaceutics, 43, 148-151.
Van den Mooter, G., Kinget, R. (1995) Oral colon-specific drug delivery: a review.Drug delivery, 2, 81-93.
V.R. Sinha, Rachna kumria (2003) Microbially triggered drug delivery to the colon.European Journal of Pharmaceutical Sciences, 18, 3-18.
V. Cardile, G. Frasca, L. Rizza, F. Bonina, C. Puglia, A. Barge, N. Chiambretti andG. Cravotto (2008) Improved adhesion to mucosal cells of water-soluble chitosantetraalkylammonium salts. International Journal of Pharmaceutics, 362, 88-92.
Tozaki, H., Komoike, J., Tada, C., Maruyama, T., Terabe, A., Suzuki, T., Yamamoto,A., Muranishi, S. (1997) Chitosan capsules for colon-specific drug delivery:Improvement of insulin absorption from the rat colon. Journal of PharmaceuticalSciences, 86, 1016?1021.
Toovey S, Hudson E, Hendry WF, Levi AJ. (1981) Sulphasalazine and maleinfertility: reversibility and possible mechanism. Gut, 22, 445-451.
Thombrea A. G., Appel L. E., Chidlaw M. B., Daugherity P. D., Dumont F., EvansL.A.F., Sutton S.C. (2004) Osmotic drug delivery using swellable-core technology.Journal of Controlled Release, 94, 75? 89.
Thi, T. D., Van Speybroeck, M., Barillaro, V., Martens, J., Annaert, P., Augustijns, P.,Augustijns, P. Van Gumbeeck, J., Vermant, Jan., and Van den Mooter, G. (2009).
Terada A., Naruto S., Wachi K., Tanaka S., Iizuka Y. and Misaka E. (1987) Synthesisand anti-inflammatory activity of [(cysloalkylmethyl) phenyl]acetic acid and relatedcompounds. Journal of Medicinal Chemistry, 27, 212-216.
Takada, K., Murakami, M. (1999) Glycyrrhizin preparations for trans-mucosalabsorption. U.S. Patent, 6890547.
Summers RW, Switz DM, Sessions JT Jr, et al. (1979) National Cooperative Crohn'sDisease Study: results of drug treatment. Gastroenterology, 77, 847-869.
Spraycar M (Ed), (1995) Stedman ?s Medical Dictionary, Maryland, Williams &Wilkins, 1332-333.
Sonali, Rahul Pratap Singh, Sunil Kumar Prajapati (2014) Formulation andevaluation of prednisolone loaded microsponges for colon drug delivery: in-vitroand pharmacokinetic study. International Journal of Pharmaceutical Science andResearch, 5(5), 1994-2005.
Snezana Milojevic, John Michael Newton, John H. Cummings, Glenn R. Gibson, R.Louise Botham, Stephen G. Ring, Mike Stockham, Mike C. Allwood (1996) Journalof Controlled Release, 38, 75-84.
Simpkins, J.W., Smulkowski, M., Dixon, R., Tuttle, R. (1988) Evidence for thedelivery of narcotic antagonists to the colon as their glucuronide conjugates. TheJournal of Pharmacology and Experimental Therapeutics, 244, 195?205.
Simon, G.L., Gorbach, S.L. (1984) Intestinal flora in health and disease.Gastroenterology, 86, 174?193.
Shun, Y.L., Ayres, J.W. (1992) Calcium alginate beads as core carriers of 5-aminosalicylic acid. Pharmaceutical Research, 9, 714?790.
Shifrine, M., Phaff, H.J. (1958) On the isolation, ecology and taxonomy ofsaccharomycopsis guttulata. Antonie van Leeuwenhoek: International Journal ofGeneral and Molecular Microbiology, 24, 193?209.
Shibasaki, J., Inoue, Y., Kadoskai, Y.K., Sasaki, H., Nakamura, J. (1985) Hydrolysisof salicyluric acid in rabbit intestinal microorganisms. Journal of Pharmacobiodynamics,8, 989?995.
Semde, R., Amighi, K., Devleeschouwe, M.J., Moes, A.J. (2000) Effect ofpectinolytic enzymes on the theophylline release from pellets coated with waterinsoluble polymers containing pectin HM or calcium pectinate. InternationalJournal of Pharmaceutics, 197, 169?179.
Savage, D.C., (1977b). Interactions between the host and microbes. In: Clarke,R.T.J., Bauchop, T. (Eds.), Microbial Ecology of the Gut. Academic Press, New York,p. 277.
Savage, D.C., (1977a) Microbial ecology of the gastrointestinal tract. Annual Reviewof Microbiology, 31, 107?133.
S. J. Kshirsagar, M. R. Bhalekar, R. R. Umap (2009) In vitro In vivo comparison oftwo pH sensitive Eudragit polymers for colon specific drug delivery. Journal ofPharmaceutical Science and Research, 1(4), 61-70.
Rubinstein, A., Radai, R., Ezra, M., Pathak, S., Rokem, J.S. (1993) In vitroevaluation of calcium pectinate: A potential colon-specific drug delivery carrier.Pharmaceutical Research, 10, 258?263.
Rubinstein, A., Radai, R. (1995) In vitro and in vivo analysis of colon specificity ofcalcium pectinate formulations. European Journal of Pharmaceutics andBiopharmaceutics, 41; 291?295.
Rubinstein, A., Nakar, D., Sintov, A., (1992) Colonic drug delivery: enhancedrelease of indomethacin from cross-linked chondroitin matrix in rat cecal content.Pharmaceutical Research, 9, 276?278.
Rubinstein, A., Nakar, D., Sintov, A. (1992) Chondroitin sulphate: A potentialbiodegradable carrier for colon-specific drug delivery. International Journal ofPharmaceutics, 84, 141?150.
Rubinstein, A. (1990) Microbially controlled drug delivery to the colon.Biopharmaceutics & Drug Disposition, 11, 465?475.
Ravindra, R., Krovvidi, K.R., Khan, A.A. (1998) Solubility parameter of chitin andchitosan. Carbohydrate Polymers, 36, 121-/127.
Rama Prasad, Y.V., Krishnaiah, Y.S., Satyanarayana, S. (1998) In vitro evaluation ofguar gum as a carrier for colon-specific drug delivery. Journal of Controlled Release,51; 281?287.
Putta Rajesh kumar, Hiremath Doddayya, Rajendra Reddy S. (2012) Design and invitro evaluation of Regioselective tablets to treat Helicobacter pylori caused pepticulcers. Novel Science International Journal of Pharmaceutical Science, 1(8), 608-615.
Press A.G., Hauptmann I. A., Hauptmann L., Fuchs B., Fuchs M., Ewe K., RamadoriG. (1998) Gastrointestinal pH profiles in patients with inflammatory bowel disease.Alimentary Pharmacology & Therapeutics, 12, 673-678.
Potts, J.E., Clendinnings, R.A., Ackard, W.B., Wiegisch, W.D. (1973) Thebiodegradability of synthetic polymers. In: Guillet, J. (Ed.), Polymer Science andTechnology, vol. 3. Plenum Press, New York, 61?79.
Pachuau L, Mazumder B (2013) Colonic drug delivery systems based on naturalpolysaccharides and their evaluation. Mini Reviews in Medicinal Chemistry, 13(13),1982-91.
Nobuhito Shibata, Tomoya Ohno, Tatsuharu Shimokawa, Zhaopeng Hu, YukakoYoshikawa, Kenjiro Koga, Masahiro Murakami and Kanji (2001) Application ofpressure-controlled colon delivery capsule to oral administration of glycyrrhizin indog. The Journal of Pharmacy and Pharmacology, 53, 441-447.
Nakamura, J., Tagami, C., Nishida, K., Sasaki, H., (1992). Unequal hydrolysis ofsalicylic acid?D-alanine and salicylic acid?L-alanine conjugate in rabbit intestinalmicroorganisms. Chemical & Pharmaceutical Bulletin, 40, 547?549.
Nakamura, J., Kido, M., Nishida, K., Sasaki, H. (1992b). Hydrolysis of salicylic acidtyrosine salicylic acid?methionine prodrugs in rabbits. International Journal ofPharmaceutics, 87; 59?66.
Nakamura, J., Asai, P., Nishida, K., Sasaki, H., (1992a) A novel prodrug of salicylicacid, salicylic acid?glutamic acid conjugate utilizing hydrolysis in rabbit intestinalmicroorganisms. Chemical & Pharmaceutical Bulletin, 40, 2164?2168.
Muzzarelli RA. (1977) Stereochemistry and physical characterization. In: MuzzarelliRA, editor. Chitin. New York: Pergamon Press, 45?86.
Murina Momin, Pundarikakshudu (2004) In vitro studies on guar gum basedformulation for the colon targeted delivery of sennosides. Journal of Pharmacy &Pharmaceutical Sciences, 7(3), 325-331.
Murali Krishna K., Narisi Reddy P., Siva Nageswara Rao T., Koteswara Rao KV.(2012) Esomeprazole Enteric Coated Intestinal Fast Dissolving Tablets ComparedWith Marketed Products. Research Journal of Pharmaceutical, Biological andChemical, 3(4), 1032-1041.
Motoki Muraoka, Zhaopeng Hu, Tatsuharu Shimokawa, Syu-ichi Sekino, Ri-eKurogoshi, Yoshiko Kuboi, Yukako Yoshikawa, Kanji Takada (1998) Evaluation ofintestinal pressure-controlled colon delivery capsule containing caffeine as a modeldrug in human volunteers. Journal of Controlled Release, 52, 119 ?129.
Moore,W.E.C., Holdeman, L.V. (1975) Discussion of current bacteriologicinvestigation of the relationships between intestinal flora, diet and colon cancer.Cancer Research, 35, 3418?3420.
Moore,W.E.C., Holdeman, L.V. (1974) Human fecal flora: the normal flora oftwenty Japanese?Hawaiians. Applied Microbiology, 27, 961?979.
Milojevic, S., Newton, J.M., Cummings, J.H., Gibson, G.R., Botham, R.L., Ring,S.G., Stockham, M., Allwood, M.C. (1996) Amylose as a coating for drug deliveryto the colon: Preparation and in vitro evaluation using glucose pellets. Journal ofControlled Release, 38, 85?94.
Mikael Larsson, Johan Hjartstam, Jolina Berndtsson, Mats Stading, Anette Larsson.(2010) Effect of ethanol on the water permeability of controlled release filmscomposed of ethyl cellulose and hydroxypropyl cellulose. European Journal ofPharmaceutics and Biopharmaceutics, (76)3, 428-432.
Marieb EN, Mallatt J. (1997) Human anatomy. Menlo Park: Benjamin andCummings, 561?99.
Marguerite Rinaudo (2006) Chitin and chitosan: Properties and applications.Progress in Polymer Science, 31, 603-632.
Malchow H, Ewe K, Brandes JW, et al. (1984) European Cooperative Crohn'sDisease Study (ECCDS): results of drug treatment. Gastroenterology, 86, 249-266.
Macy, J.M. (1979) The biology of gastrointestinal Bacteroides. Annual Review ofMicrobiology, 33, 561?594.
M.K. Chourasia, S.K. Jain (2003) Pharmaceutical approaches to colon targeted drugdelivery system. Journal of Pharmacy and Pharmaceutical Sciences, 6(1), 33-66.
Lorenzo-Lamosa, M.L., Remunan-Lopez, C., Vila-Jato, J.L., Alonson, M.J. (1998)Design of microencapsulated chitosan microspheres for colonic drug delivery.Journal of Controlled Release, 52, 109?118.
LinShu Liua,, Marshall L. Fishmana, Joseph Kostb, Kevin B. Hicks (2003) Pectinbasedsystems for colon-specific drug delivery via oral route. Biomaterials, 243333?3343.
Libo Yang, Shunsuke Watanabe, Jinhe Li, James S. Chu, Masataka Katsuma,Shigeharu Yokohama, and Joseph A. (2003) Effect of Colonic Lactulose Availabilityon the Timing of Drug Release Onset in Vivo from a Unique Colon-Specific DrugDelivery System (CODES??). Pharmaceutical Research, 20(3), 429-434.
Levi AJ, Fisher AM, Hughes L, Hendry WF. (1979) Male infertility due tosulphasalazine. Lancet, Lond 2; 276-278.
Lee, S-S., La, S-B., Lim, C-B., Lee, S., Seo, B-Y., Pai (1997) Colon selective drugdelivery composition. U.S. Patent, 6319518.
Lee F. Siew, Sit-Ming Man, J. Michael Newton, Abdul W. Basit (2004) Amyloseformulations for drug delivery to the colon: a comparison of two fermentationmodels to assess colonic targeting performance in vitro. International Journal ofPharmaceutics, 273, 129?134.
Krishnaiah Y.S.R., Satyanarayana S., Rama Prasad Y.V., Narasimha Rao S. (1998b)Gamma scintigraphic studies on guar gum matrix tablets for colonic drug delivery inhealthy human volunteers. Journal of Controlled Release, 55, 245?252.
Krishnaiah Y.S.R,, Satyanarayana S, Rama Prasad Y.V., Narasimha Rao S. (1998a)Evaluation of guar gum as a compression coat for drug targeting to colon.International Journal of Pharmaceutics, 171, 137?146.
Kinget, R., Kalala, W., Vervoort, L., Mooter, G.U. (1998) Colonic drug targeting.Journal of Drug Targeting, 6, 129?149.
Kincl, M., Turk, S., and Vre?er, F. (2005) Application of experimental designmethodology in development and optimization of drug release method. InternationalJournal of Pharmaceutics, 291, 39-49.
Khan, K.A. (1975) The concept of dissolution efficiency. The Journal of Pharmacyand Pharmacology, 27(1), 48-49.
Khan, A.K.A., Piris, J., Truelone, S.C. (1977) An experiment to determine the activetherapeutic moiety of sulphasalazine. Lancet, Lond, 2, 895?896.
Kannadasan Ma, Ram Kumar Rb, and Vijay Kumar Sc. (2014) Review article:Pharmaceutical approaches to colon targeted drug delivery systems. ResearchJournal of Pharmaceutical, Biological and Chemical, 5(5), 1811-1822.
Jose S, Prema MT, Chacko AJ, Thomas AC, Souto EB. (2011) Colon specificchitosan microspheres for chronotherapy of chronic stable angina. Colloids and121Surfaces. B: Biointerfaces, 1, 83(2), 277-83.
Jolanta Kumirska, Mirko X. Weinhold, Ma??gorzata Czerwicka, Zbigniew Kaczy?ski,Anna Bychowska, Krzysztof Brzozowski, Jorg Thoming, and Piotr Stepnowski(2011) Influence of the chemical structure and physicochemical properties of chitinandchitosan-based materials on their biomedical activity. Biomedical Engineering,Trends in Materials Science, chapter 2.
Illum L. (1988) Chitosan and its use as a pharmaceutical excipient. PharmaceuticalResearch, 15, 1326?31.
Hui Liu, Xing-Gang Yang, Shu-Fang Nie, Lan-Lan Wei, Li-Li Zhoub, Hong Liu,Ren Tang, Wei-San Pan (2007) Chitosan-based controlled porosity osmotic pump forcolon-specific delivery system: Screening of formulation variables and in vitroinvestigation. International Journal of Pharmaceutics, 332, 115?124.
Hua Zhang, Steven H. Neau (2002) In vitro degradation of chitosan by bacterialenzymes from rat cecal and colonic contents. Biomaterials, 23, 2761?2766.
Hovgaard, L., Brondsted, H. (1996) Current applications of polysaccharides in colontargeting. Critical Reviews in Therapeutic Drug Carrier Systems, 13, 185?223.
Hill, M.J., Drasar, B.S. (1975) The normal colonic bacterial flora. Gut 16, 318?323.
Hawksworth G, Drasar BS, Hill MJ. (1971) Intestinal bacteria and hydrolysis ofglycosidic bonds. Journal of Medical Microbiology, 4, 451?459.
Harboe, E., Larsen, C., Johansen, J. (1988) Macromolecular prodrug. X.Bioavailability of naproxen after oral administration of dextran?naproxen esterconjugates in rabbits. Farmaci Sci. Ed. 16, 65?72.
Gurpreet Kaur, Vikas Rana, Subheet Jain, and Ashok K. Tiwary (2009) Colondelivery of budesonide: Evaluation of chitosan?chondroitin sulfate interpolymercomplex. AAPS PharmSciTech, 11(1), 36-45.
Gurpreet Kaur, Maninderjit kaur, Harpreet kaur, Saurav Sharma (2013) Colonspecific drug delivery systems: A review on different approaches to treat colondisease. International Journal of Pharmaceutica Research and Development, 5(08),71-83.
Gurpreet KAUR, Subheet JAIN, Ashok K. TIWARY (2010) Chitosancarboxymethyltamarind kernel powder interpolymer complexation: Investigationsfor colon drug delivery. Scientia Pharmaceutica, 78, 57-78.
Gorbach, S.L., Plavt, A.g., Nahas, L., Weinstein, L. (1967) Studies of intestinalmicroflora. II. Microorganism of the small intestine and their relations to oral andfecal flora. Gastroenterology 53, 856?867.
Gorbach, S.L., Levitan, R. (1970) Intestinal flora in health and in gastrointestinaldiseases. In: Glass, G.B.J. (Ed.). Progress in Gastroenterology, 2, 252?275.
Gliko-Kabir, I., Yagen, B., Baluom, M., Rubinstein, A. (2000) Phosphated crosslinkedguar for colon-specific drug delivery. II. In vitro and in vivo evaluation in therat. Journal of Controlled Release, 63, 129?134.
Garry Kercha, Janis Zicansb, Remo Merijs Merib (2010) The effect of chitosanoligosaccharides on bread staling, Journal of Cereal Science, 52; 491-495.
Fukui E, Miyamura N, Uemura K, Kobayashi M. (2000) Preparation of entericcoated timed release press-coated tablets and evaluation of their function by in vitroand in vivo tests for colon targeting. International Journal of Pharmaceutics, 204, 7-15.
Fu-Yin Hsu ? Ding-Syuan Yu ? Chun-Chiang Huang (2013) Development of pHsensitivepectinate/alginate microspheres for colon drug delivery. Journal ofMaterials Science. Materials in Medicine, 24, 317?323.
Friend, D.R., Phillips, S., McLeod, A., Tozer, T.N. (1991) Relative inflammatoryeffect of oral dexamethasone-b-D-glucoside and dexa-methasone in experimentalinflammatory bowel disease in guinea pig. The Journal of Pharmacy andPharmacology, 43; 353?355.
Friend, D.R., Chang, G.W. (1985) Drug glycosides: Potential prodrugs for colonspecific drug delivery. Journal of Medicinal Chemistry, 28, 51?57.
Friend, D.R., Chang, G.W. (1984) A colon-specific drug delivery system based ondrug glycosides and glycosidase of colonic bacteria. Journal of MedicinalChemistry, 27, 261?266.
Friend D.R. (1997) Issues in lower gastrointestinal drug delivery. PharmaceuticalNews, 4, 12-15.
Formulate ability of ten compounds with different physicochemical profiles inSMEDDS. European Journal of Pharmaceutical Sciences, 38(5), 479-488.
Finegold, S.M., Sutter, V.L., Sugihara, P.T., Elder, H.A., Lehman, S.M., Phillips, R.L.(1977) Fecal microbial flora in Seventh Day Adventist population and controlsubjects. The American Journal of Clinical Nutrition, 30, 1718?1792.
Dupuis G, Chambin O, Genelot C, Champion D, Pourcelot Y. (2006) Colonic drugdelivery: influence of cross-linking agent on pectin beads properties and role of theshell capsule type. Drug Development and Industrial Pharmacy, 32(7), 847-55.
Dubal Ashwini, Karigar Asif, Ramana MV, Patel Mitul, Desai Omkar (2011)Chonotheraphy: A Novel drug delivery system. International Journal of Basic andApplied Physiology, 2(6), 1692-1700.
Dong-Ying Xu, Guang-Ji Li, Zheng-Fu Liao, Xiao-Hong He (2009) Preparation andin vitro controlled release behavior of a novel pH-sensitive drug carrier for colondelivery, Polymer Bulletin, 62(2), 183?193.
Debongnie, J.C., Phillips, S.F. (1978) Capacity of the human colon to absorb fluid.Gastroenterology, 74, 698?703.
Chourasia M.K., Jain S.K. (2003) Pharmaceutical approaches to colon targeted drugdelivery system. Journal of Pharmacy and Pharmaceutical Sciences, 6(1), 33-66.
Chan, R.P., Pope, D.J., Gilbett, A.P., Sneta, P.J., Baron, J.H., Bennard Jones, J.F.(1983) Studies of two novel sulphasalazine analogs ipsalazide and balsalazide.Digestive Diseases and Sciences, 28, 609?716.
Cantarini L, Tinazzi I, Biasi D, Fioravanti A, Galeazzi M (2007) Sulfasalazineinducedimmune thrombocytopenia. Postgraduate Medical Journal, 83(980), e1-e2.
Bussemer T, Otto Bodmeier IR. (2003) Pulsatile drug-delivery systems. Crit. Rev.Ther. Drug Carrier System, 18, 433-458.
Brondsted, H., Andersen, C., Hovgaard, L. (1998) Cross linked dextran?a newcapsule material for colon targeting of drug. Journal of Controlled Release, 53, 7?13.
Brahma N. Singh (2007) Modified-release solid formulations for colonic delivery.Recent Patents on Drug Delivery & Formulation, 1, 53-63117
Barbara Haeberlin, David R. Friend, (1992) Chapter 1. Anatomy and physiology ofthe GI tract: Implications for colonic drug delivery, Edited by David R. Friend, OralColon Specific Drug Delivery, 1?44.
Aiedeh, K., Taha, M.O. (1999) Synthesis of chitosan succinate and chitosanphthalate and their evaluation as suggested matrices in orally administered, colonspecific drug delivery system. Archiv der Pharmazie, 332, 103?107.
Ahrabi, S.F., Madsen, G., Dyrstad, K., Sande, S.A., Graffner, C. (2000)Development of pectin matrix tablets for colonic delivery of model drug ropivacaine.European Federation for Pharmaceutical Sciences, 10, 43?52.
Adkin, A.D., Kenyon, C.J., Lerner, E.I., Landau, I., Strauss, E., Caron, D., Penhasi,A., Rubinstein, A., Wilding, I.R. (1997) The use of sci-ntigraphy to provide proof ofconcept ? for novel polysaccharide preparation designed for colonic drug delivery.Pharmaceutical Research, 14, 103?107.
Abraham Rubinstein, Raphael Radai, Miriam Ezra, Seema Pathak, and J. StefanRokem (1993) In vitro Evaluation of Calcium Pectinate: A Potentail Colon-specificDrug delivery carrier. Pharmaceutical Research, 10(2), 258-263
